Brainomix Nominated for Prestigious Prix Galien Award

Brainomix's e-Stroke platform was nominated as a finalist candidate for "Best Digital Health Solution," a competitive category with 11 other companies and their highly innovative technologies.

"We were honored to be nominated for a Prix Galien Award," noted Dr Michalis Papadakis, CEO and Co-Founder of Brainomix. "It's a recognition of the groundbreaking work that our team have accomplished over the years with the development of our e-Stroke platform, which continues to provide clinicians with cutting-edge, novel solutions that help optimize stroke care across the world."